Gossamer Bio, Inc.
GOSS· Nasdaq
GOSSGossamer Bio, Inc.
Filed Aug 8, 2019 · 10-Q · 39 days after period end · 0001564590-19-030814
| Metric | Q2 2019 | Q2 2018 |
|---|---|---|
| Net Income | -$44.50M | -$32.73M |
| EPS Diluted | -$0.74 | -$5.52 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Gossamer Bio, Inc. · CIK 1728117 · Engraved from SEC EDGAR
ended Jun 30, 2019 · filed Aug 8, 2019 · 39 d after period end
